Promoting children's health through understanding of genetics and genomics

Journal of Nursing Scholarship

Volumn 37, Issue 4, 2005, Pages 308-314

  Kenner, Carole ^a   Gallo, Agatha M ^b   Bryant, Kellie D ^c  

^a UNIVERSITY OF OKLAHOMA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c LONG ISLAND UNIVERSITY   (United States)

Author keywords

Congenital hearing loss; Genetic testing; Pediatric nursing; Sickle cell disease; Usher syndrome

Indexed keywords

GENETIC DISORDER; GENETIC SCREENING; GENETICS; HEALTH PROMOTION; HUMAN; HUMAN GENOME PROJECT; NEWBORN; NEWBORN SCREENING; REVIEW; SICKLE CELL ANEMIA; USHER SYNDROME;

ANEMIA, SICKLE CELL; GENETIC DISEASES, INBORN; GENETIC SCREENING; HEALTH PROMOTION; HUMAN GENOME PROJECT; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; USHER SYNDROMES;

EID: 33644849465     PISSN: 15276546     EISSN: 15475069     Source Type: Journal    
DOI: 10.1111/j.1547-5069.2005.00054.x     Document Type: Review

References (47)

1. Adams, R.J. (2000). Lessons learned from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study. Journal of Pediatric Neurology, 15, 344 349.
2. Adams, G.T., Snieder, H., McKie, V.C., Clair, B., Brambilla, D., Adams, R.J., et al. (2003). Genetic risk factors for cerebrovascular disease in children with sickle cell disease: Design of a case-control association study and genomewide screen. BioMed Central Medical Genetics, 4 (1 6.
3. American Academy of Pediatrics (AAP), Section on Hematology/Oncology, Committee on Genetics 2002). Health supervision for children with sickle cell disease. Pediatrics, 109 (3 526 535.
4. Ashley-Koch, A., Yang, Q., & Olney, R.S. (2000). Sickle hemoglobin (HbS) allele and sickle cell disease: A HuGE review. American Journal of Epidemiology, 151 (9 839 845.
5. Beutler, E. (2001). Discrepancies between genotype and phenotype in hematology: An important frontier. Blood, 98 (9 2597 2602.
6. Boys Town National Research Hospital n.d.). The national center for the study and treatment of Usher syndrome. Retrieved August 16, 2005, from http://www.boystownhospital.org/usher/index.asp
7. Brown, E.W. (1998). The urgent need for early detection of deafness in infants. Medical Update, 22, 2.
8. Buchanan, G.R., DeBaun, M.R., Quinn, C.T., & Steinberg, M.H. (2004). Sickle cell disease. Hematology, 1, 35.
9. Chui, D., & Dover, G. (2001). Sickle cell disease: No longer a single gene disorder. Current Opinion Pediatrics, 13, 23 37.
10. Early diagnosis of Usher syndrome type 1 made possible by new findings 2003). Retrieved May 20, 2005, from http://www.nicd.nih.gov/news/releases/03/ 04_23_03.asp
11. Feetham, S., Thomson, E.J., & Hinshaw, A.S. (2005). Nursing leadership in genomics for health and society. Journal of Nursing Scholarship, 37, 102 110.
12. Fullerton, H.J., Adams, R.J., Zhao, S., & Johnston, S. (2004). Declining stroke rates in children with sickle cell disease. Blood, 104, 336 339.
13. Gilbert, F. (2001). Cystic fibrosis carrier screening: Steps in the development of a mutation panel. Genetic Testing, 5 (3 223 227.
14. Hoppe, C., Klitz, W., Vigil, L., Vichinsky, E., & Styles, L. (2003). Distinct HLA associations by stroke subtype in children with sickle cell anemia. Blood, 101 (7 2865 2869.
15. Hoppe, C., Klitz, W., Cheng, S., Apple, R., Steiner, L., Robles, L., et al. (2004). Gene interactions and stroke risk in children with sickle cell anemia. Blood, 103 (6 2391 2396.
16. Houdayer, C., Lourdaux, J., Billette de Villemeur, T., Royer-Legrain, G., Bahuau, M., Bonnefont, J.P., et al. (2002). Simple fluorescent PCR assay for discriminating FRAXA fully mutated females from normal homozygotes. Genetic Testing, 6 (2 135 139.
17. Kimberling, W.J., Weston, M.D., & Orten, D.J. (2004). Usher syndrome type II. Retrieved May 20, 2005, from http://www.genetests.org
18. Kimberling, W.J., Weston, M.D., & Pieke-Dahl, S.P. (2004, February 6). Usher syndrome type I. Retrieved May 20, 2005, from http://www.genetests.org
19. Kirkham, F. (2003). Is there a genetic basis for pediatric stroke? Current Opinion in Pediatrics, 15 (6 547 558.
20. Lashley, F.R. (2002). Newborn screening: New opportunities and new challenges. Newborn and Infant Nursing Reviews, 2 (4 228 242.
21. Levy, H.L. (2003). Lessons from the past? Looking to the future. Newborn screening. Pediatric Annals, 32 (8 505 508.
22. Luo, H., Adewoye, A.H., Eung, S., Skelton, T.P., Quillen, K., McMahon, L., et al. (2004). A novel sickle hemoglobin: Hemoglobin S-South End. Journal of Pediatric Hematology/Oncology, 26 (11 773 776.
23. Martin, J.A., Hamilton, B.E., Sutton, P.D., Ventura, S.J., Menacker, F., & Munson, M.L. (2003). Births: Final data for 2002. National Vital Statistics Report, 52 (10 1 114.
24. Meschia, J.G., & Pankratz, V.S. (2005). Defining stroke risk in sickle cell anemia. Nature Genetics, 37, 340 341.
25. Milner, P.F., Kraus, A.P., Sebes, J.I., Sleeper, L.A., Dukes, K.A., & Embury, S.H. (1991). Sickle cell disease as a cause of osteonecrosis of the femoral head. New England Journal of Medicine, 325, 1476 1481.
26. Moore, C.A., Khoury, M.J., & Bradley, L.A. (2005, June). From genetics to genomics: Using gene-based medicine to prevent and promote health in children. Seminars in Perinatology, 29 (3 135 143.
27. Murray, N., Serjeant, B.E., & Serjeant, G.R. (1988). Sickle cell-hereditary persistence of fetal haemoglobin and its differentiation from other sickle cell syndromes. British Journal of Haematology, 69, 89 92.
28. Nadeau, J.H. (2005). Listening to genetic background noise. New England Journal of Medicine, 352 (15 1598 1599.
29. National Coalition of Health Professional Education in Genetics 2004). Core competencies in genetics essential for all health-care professionals. Retrieved June 20, 2004, from http://www.nchpeg.org/nchpeg.html? http://www.nchpeg.org/eduresources/core/core.asp
30. National Institutes of Health 2003, November 19-21). Conference summary: New directions for sickle cell therapy in the genome era. Retrieved November 20, 2004, from http://www.genome.gov/11509561
31. Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury, S., Moohr, J.W., et al. (1998). Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood, 91, 288 294.
32. Quinn, C.T., & Miller, S.T. (2004). Risk factors and prediction of outcomes in children and adolescents who have sickle cell anemia. Hematology/oncology Clinics of North America, 18 (6 1339 1354.
33. Quinn, C.T., Rogers, Z.R., & Buchanan, G.R. (2004). Survival of children with sickle cell disease. Blood, 103 (11 4023 4027.
34. Schatz, J., Finke, R.B.S., & Roberts, C.W. (2004). Interactions of biomedical and environmental risk factors for cognitive development: A preliminary study of sickle cell disease. Journal of Developmental & Behavioral Pediatrics, 25 (5 303 310.
35. Sebastiani, P., Ramoni, M.F., Nolan, V., Baldwin, C.T., & Steinberg, M.H. (2005). Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nature Genetics, 37, 435 444.
36. Smith, R.J., Green, G.E., & Van Camp, G. (2003). Deafness and hereditary hearing loss. Retrieved May 29, 2004, from http://www.geneclinics. org/profiles/deafness-overview/details.html
37. Steinberg, M.H., Rosenstock, W., Coleman, M.B., Adams, J.G., Platica, O., & Cedeno, M. (1984). Effects of thalassemia and microcytosis on the hematologic and vasooclusive severity of sickle cell anemia. Blood, 63, 1353 1360.
38. Steinberg, M.H. (2001). Compound heterozygous and other sickle hemoglobinopathies. In M.J. Steinberg, B.G. Forget, D.R. Higgs, & R.L. Nagel (Eds. Disorders of hemoglobin genetics, pathophysiology, and clinical management (pp. 786 810). Cambridge, MA : Cambridge University Press.
39. Steinberg, M.H., & Brugnara, C. (2003). Pathophysiological-based approaches to treatment of sickle cell disease. Annual Review of Medicine, 54, 89 112.
40. Styles, L.A., Hoppe, C., Klitz, W., Vichinsky, E., Lubin, B., & Trachtenberg, E. (2000). Evidence for HLA-related susceptibility for stroke in children with sickle cell disease. Blood, 95, 3562 3567.
41. Taylor, J.G.T., Tang, D.C., Savage, S.A., Leitman, S.F., Heller, S.I., Sergeant, G.R., et al. (2002). Variant in the VCAM1 gene and risk of symptomatic stroke in sickle cell disease. Blood, 100, 4303 4309.
42. Thomas, P.W., Higgs, D.R., & Serjeant, G.R. (1997). Benign clinical course in homozygous sickle cell disease: A search for predictors. Journal of Clinical Epidemiology, 50, 121 126.
43. Usher Syndrome 2003, February 23). Retrieved May 20, 2005, from http://www.nidcd.nih.gov/health/hearing/usher.asp
44. Usher Syndrome Type II 2005, May 13). Retrieved May 20, 2005, from http://ghr.nlm.nih.gov/condition=ushersyndrometypeii
45. Usher Syndrome Type III 2005). Retrieved May 20, 2005 from http:/ghr.nlm.nih.gov/condition=ushersyndrometypeiii.
46. Vichinsky, E., & Schlis, K. (2003). Sickle cell disease. Gene reviews. Retrieved December 31, 2004, from http://www.geneclinics.org/servlet/ access?id=8888891&key=G1Jpe7vE9z8Ch&gry=INSERTGRY&fcn=y&fw= th91&filename=/profiles/sickle/index.html
47. Weatherall, D.J. (2003). Pharmacological treatment of monogenic disease. The Pharmacogenomics Journal, 3 (5 264 266.